安琪酵母(600298) - 2023 Q4 - 年度财报

Financial Performance - The company reported an undistributed profit of RMB 7,004,943,502.19 as of the end of 2023, with an undistributed profit per share of RMB 8.06[4] - The capital reserve at the end of 2023 was RMB 2,440,394,880.25, translating to a capital reserve per share of RMB 2.81[4] - The proposed cash dividend distribution is RMB 5 per 10 shares, amounting to an estimated total distribution of RMB 428,862,885.50[4] - The company has a total share capital of 868,752,279 shares, adjusted for repurchased shares, resulting in a base of 857,725,771 shares for the dividend distribution[4] - The company's operating revenue for 2023 reached ¥13,581,131,635.82, representing a year-on-year increase of 5.74% compared to ¥12,843,297,523.48 in 2022[19] - The net profit attributable to shareholders of the listed company for 2023 was ¥1,270,164,997.63, a decrease of 3.86% from ¥1,321,207,397.24 in 2022[19] - The net cash flow from operating activities for 2023 was ¥1,320,869,622.10, showing an increase of 23.58% compared to ¥1,068,813,772.57 in 2022[19] - The total assets at the end of 2023 amounted to ¥19,270,410,479.20, reflecting a year-on-year growth of 13.80% from ¥16,933,432,292.02 in 2022[19] - The basic earnings per share for 2023 was ¥1.47, down 6.37% from ¥1.57 in 2022[20] - The weighted average return on equity for 2023 was 13.03%, a decrease of 3.44 percentage points from 16.47% in 2022[20] - The company reported non-recurring gains of ¥165,719,771.36 for 2023, compared to ¥207,076,472.59 in 2022[23] - The net profit after deducting non-recurring gains for 2023 was ¥1,104,445,226.27, a slight decrease of 0.87% from ¥1,114,130,924.65 in 2022[19] Operational Highlights - The first quarter of 2023 saw operating revenue of ¥3,396,542,504.36, with a net profit of ¥352,412,349.97[22] - The total fermentation output reached 376,900 tons, a year-on-year increase of 15.09%[27] - The revenue from international business was 4.786 billion RMB, a year-on-year increase of 21.99%[26] - The company successfully developed new yeast strains, with the yeast protein approved as a new food material[27] - The company participated in 295 industry events and conferences to enhance market presence[26] - The company is the second largest yeast producer globally, with a significant market share in China[30] - The company achieved a revenue of 13.581 billion yuan, representing a year-on-year growth of 5.74%[37] - The total yeast fermentation capacity reached 370,000 tons, with a domestic market share of 55% and a global market share exceeding 18%[33] - The company operates in 13 cities globally, including 11 domestic and 2 overseas production bases[33] - The company has established a comprehensive marketing network, selling products in over 160 countries and regions[36] Research and Development - The company applied for 159 patents during the reporting period, with 90 patents granted[34] - Research and development expenses rose by 12.55% to 603.43 million RMB, indicating a continued investment in innovation[39] - The company employed 816 R&D personnel, making up 6.86% of the total workforce, with a significant portion holding master's degrees[55] - The company plans to invest 200 million yuan in new technology over the next two years[92] - Research and development expenses increased by 18%, focusing on innovative fermentation technologies[92] Governance and Compliance - The company has maintained a standard unqualified audit report from Da Xin Accounting Firm[3] - The board of directors and supervisory board members have all attended the board meeting, ensuring accountability for the report's accuracy[3] - The company emphasizes that forward-looking statements do not constitute substantive commitments to investors, highlighting the importance of investment risk awareness[5] - The company held 4 shareholder meetings during the reporting period, approving a total of 28 proposals, ensuring compliance with legal and regulatory requirements[78] - The board of directors consists of 11 members, including 6 independent directors, and held 12 meetings during the reporting period, approving 57 proposals[80] - The supervisory board, composed of 3 members, held 12 meetings and approved 43 proposals, ensuring compliance with legal regulations[80] - The company disclosed 170 announcements in 2023, including 114 announcements and 56 attachments, fulfilling information disclosure obligations[80] Environmental Responsibility - The company invested ¥67,468.38 million in environmental protection during the reporting period[128] - The company has 20 key pollution discharge outlets, all of which are compliant with discharge standards[129] - The company achieved a chemical oxygen demand discharge concentration of 74 mg/L, which is below the standard limit of 150 mg/L[129] - The company reported a total annual emission of 1,197.63 tons for chemical oxygen demand and 1,076.10 tons for nitrogen oxides in 2023[131] - The company successfully started production at the Keke Dala and Puer companies, adding one wastewater and one gas discharge outlet each[132] - The company has implemented comprehensive environmental monitoring systems for wastewater and air emissions, ensuring compliance with regulatory standards[137] - The company has engaged in community outreach programs, including educational donations totaling 1 million yuan to support scholarships[144] Shareholder and Capital Management - The total cash dividend amount (including tax) is 578,848,407.96 RMB, representing 45.57% of the net profit attributable to ordinary shareholders in the consolidated financial statements[120] - The company plans to repurchase between 8,444,444 and 10,666,667 shares, representing 0.97% to 1.23% of the total share capital[200] - The total amount allocated for the share repurchase is between 380 million RMB and 480 million RMB[200] - The total number of shares decreased from 868,968,879 to 868,752,279 due to the cancellation of restricted stocks[181] - The company unlocked 2,662,400 shares from the restricted stock incentive plan during the reporting period[182] - The company repurchased a total of 4,176,563 shares, accounting for 0.48% of the total share capital[185] Future Outlook - The company aims to achieve a revenue target of CNY 15.669 billion in 2024, reflecting a year-on-year growth of 15.37%[73] - The net profit attributable to shareholders is projected to be CNY 1.369 billion in 2024, an increase of 7.80% year-on-year[73] - The company plans to focus on five key industries: yeast, health food ingredients, nutritional health food, new biotechnology, and new health packaging[72] - The company is positioned to become the world's largest yeast producer and a leading international biotechnology company[72] - The company plans to strengthen market control and adjust sales strategies based on market conditions to create differentiated products and services[75]